123
Views
4
CrossRef citations to date
0
Altmetric
Methodology

Simultaneous Determination of Parecoxib and Its Metabolite Valdecoxib Concentrations in Beagle Plasma by UPLC-MS/MS and Application for Pharmacokinetics Study

ORCID Icon, , , , &
Pages 1117-1125 | Published online: 13 Mar 2020

References

  • DwivediAK, GurjarV, KumarS, SinghN. Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs). Drug Discov Today. 2015;20(7):863–873. doi:10.1016/j.drudis.2015.03.00425794602
  • RouzerCA, MarnettLJ. Cyclooxygenases: structural and functional insights. J Lipid Res. 2009;50(Suppl):S29–34. doi:10.1194/jlr.R800042-JLR20018952571
  • RostomA, MuirK, DubeC, et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a cochrane collaboration systematic review. Clin Gastroenterol Hepatol. 2007;5(7):818–828, 828 e811–815; quiz 768. doi:10.1016/j.cgh.2007.03.011
  • HawkeyCJ. COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol. 2001;15(5):801–820. doi:10.1053/bega.2001.023611566042
  • SchaferAI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995;35(3):209–219. doi:10.1002/j.1552-4604.1995.tb04050.x7608308
  • LanasA, Garcia-RodriguezLA, ArroyoMT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731–1738. doi:10.1136/gut.2005.08075416687434
  • NadesalingamK, KirbyD. Cardiovascular safety of non-steroidal anti-inflammatory drugs. Br J Gen Pract. 2013;63(617):632. doi:10.3399/bjgp13X675377
  • SchugSA, ParsonsB, LiC, XiaF. The safety profile of parecoxib for the treatment of postoperative pain: a pooled analysis of 28 randomized, double-blind, placebo-controlled clinical trials and a review of over 10 years of postauthorization data. J Pain Res. 2017;10:2451–2459. doi:10.2147/JPR.S13605229066931
  • KrankeP, MorinAM, RoewerN, EberhartLH. Patients’ global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg. 2004;99(3):797–806. (). doi:10.1213/01.ANE.0000133139.68208.9215333414
  • JoshiGP, RawalN, KehletH, et al. Evidence-based management of postoperative pain in adults undergoing open inguinal hernia surgery. Br J Surg. 2012;99(2):168–185. doi:10.1002/bjs.v99.221928388
  • NagappaM, WeingartenTN, MontandonG, SprungJ, ChungF. Opioids, respiratory depression, and sleep-disordered breathing. Best Pract Res Clin Anaesthesiol. 2017;31(4):469–485. doi:10.1016/j.bpa.2017.05.00429739536
  • VadiveluN, LumermannL, ZhuR, KodumudiG, ElhassanAO, KayeAD. Pain control in the presence of drug addiction. Curr Pain Headache Rep. 2016;20(5):35. doi:10.1007/s11916-016-0561-027068665
  • LeeYZ, LeeRQ, ThinnKK, PoonKH, LiuEH. How patients fare after anaesthesia for elective surgery: a survey of postoperative nausea and vomiting, pain and confusion. Singapore Med J. 2015;56(1):40–46. doi:10.11622/smedj.201500825640098
  • PleinLM, RittnerHL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175(14):2717–2725. doi:10.1111/bph.v175.1428213891
  • GuastellaA, LatchmanJ, TofthagenCS. Opioid-induced hyperalgesia: clinical implications for advanced practice nurses in oncology. Clin J Oncol Nurs. 2017;21(3):294–296. doi:10.1188/17.CJON.294-29628524890
  • HuangA, AzamA, SegalS, et al. Chronic postsurgical pain and persistent opioid use following surgery: the need for a transitional pain service. Pain Manag. 2016;6(5):435–443. doi:10.2217/pmt-2016-000427381204
  • MalanTP, MarshG, HakkiSI, GrossmanE, TraylorL, HubbardRC. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology. 2003;98(4):950–956. doi:10.1097/00000542-200304000-0002312657858
  • NakataK, HanaiT, TakeY, et al. Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review. Osteoarthr Cartilage. 2018;26(10):1263–1273. doi:10.1016/j.joca.2018.05.021
  • ZhangH, LiuX, JiangH, LiuZ, ZhangXY, XieHZ. Parecoxib increases muscle pain threshold and relieves shoulder pain after gynecologic laparoscopy: a randomized controlled trial. J Pain Res. 2016;9:653–660. doi:10.2147/JPR.S11588927695359
  • BajajP, BallaryCC, DongreNA, BaligaVP, DesaiAA. Role of parecoxib in pre-emptive analgesia: comparison of the efficacy and safety of pre- and postoperative parecoxib in patients undergoing general surgery. J Indian Med Assoc. 2004;102(5):272,274, 276–278.15636035
  • GiorgiM, SaccomanniG, Del CarloS, ManeraC, LavyE. Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles. Vet J. 2012;193(1):246–250. doi:10.1016/j.tvjl.2011.11.00522130459
  • KimTW, VercelliC, BrigantiA, ReG, GiorgiM. The pharmacokinetics and in vitro/ex vivo cyclooxygenase selectivity of parecoxib and its active metabolite valdecoxib in cats. Vet J. 2014;202(1):37–42. doi:10.1016/j.tvjl.2014.07.02525135338
  • FentonC, KeatingGM, WagstaffAJ. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Drugs. 2004;64(11):1231–1261. doi:10.2165/00003495-200464110-0000615161329
  • YuQY, YuQL, WuL, et al. Validated stability-indicating RP-HPLC method for the determination of parecoxib sodium and degradation impurities in bulk drug. Curr Pharm Anal. 2017;13(3):271–278. doi:10.2174/1573412912666160418165539
  • LiuM, YuQ, LiP, et al. Simultaneous determination of parecoxib sodium and its active metabolite valdecoxib in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study after intravenous and intramuscular administration. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1022:220–229. doi:10.1016/j.jchromb.2016.04.009
  • JinXL, ZhouF, LiuY, et al. Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice. J Pharmaceut Biomed. 2018;158:1–7. doi:10.1016/j.jpba.2018.05.034
  • US Food and Drug Administration. Guidance for Indus-try: Bioanalytical Method Validation. Rockville, MD, USA: US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research; 2018 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioanalyticalmethod-validation-guidance-industry. Accessed 810, 2018..
  • ZhuYL, LiSL, ChenKL, MaKP, WuDQ, QiuXJ. Effect of Chinese herb Danzhi Xiaoyao pills on pharmacokinetics of venlafaxine in Beagles. Drug Des Dev Ther. 2019;13:3343–3355. doi:10.2147/DDDT.S221927
  • MaoZS, WangX, LiBX, et al. A simplified LC-MS/MS method for rapid determination of cycloserine in small-volume human plasma using protein precipitation coupled with dilution techniques to overcome matrix effects and its application to a pharmacokinetic study. Anal Bioanal Chem. 2017;409(11):3025–3032. doi:10.1007/s00216-017-0249-228224247
  • YeWJ, LinXJ, ZhangYT, et al. Quantification and pharmacokinetics of alpinetin in rat plasma by UHPLC-MS/MS using protein precipitation coupled with dilution approach to eliminate matrix effects. J Pharmaceut Biomed. 2018;152:242–247. doi:10.1016/j.jpba.2017.12.046